Introduction
When classical surgical reconstruction techniques for mitral valve repair are applied, a major goal is stabilization [in degenerative mitral regurgitation (MR)] or reduction (in functional MR) of the mitral valve annulus diameter via annuloplasty in addition to reconstruction of the mitral valve leaflets. This approach was introduced by Carpentier in the 1960s using an annuloplasty ring. With respect to interventional mitral valve reconstruction, there are different principles. At the moment, five percutaneous systems exist for mitral valve repair. Four of those (the CardioBand V R system, the Carillon V R System, the Mitralign V R system, and the Accucinch V R device) aim to reduce the mitral annulus diameter via insertion of annuloplasty devices. The most often used device however, the MitraClip V R system, is emulating the surgical technique of Alfieri, for which an edge-to-edge suture of both mitral valve leaflets creates a double orifice. 1 Several studies using surgical techniques have described favourable results as well after edge-to-edge repair alone as after edge-to-edge repair in combination with annuloplasty. 2, 3 The initial surgical technique for mitral valve repair encompassed resection of superfluous leaflet material. Over time it was, however, discovered that additional tightening of the mitral annulus via insertion of a annuloplasty ring led to better long term results with lesser recurrence of MR, than reconstruction of the leaflets alone. 4 Recently, a study reported a high recurrence rate of MR despite annuloplasty in patients with ischaemic MR. 5 While ring-annuloplasty is part of most surgically performed mitral valve repair operations and its benefit is generally acknowledged, it is not clear, whether this also holds true for interventional mitral valve repair and if interventional annuloplasty should be combined with edge-to-edge repair using the MitraClip V R system. This study was carried out to determine, whether percutaneous mitral valve repair (PMVR) using the MitraClip V R system can per se achieve reduction in mitral valve annular diameter-one of the main goals of surgical mitral valve repair-and whether this is associated with procedural success.
Methods

Study population
In this study, we included 183 patients with grade 2þ to 4 MR, who underwent PMVR using the MitraClip V R system (Abbott Vascular) at the University hospital, Department of Cardiology and Cardiovascular Medicine, University of Tuebingen between May 2014 and July 2016. Echocardiograms acquired after induction of anaesthesia at the beginning and at the end of the PMVR procedure and at follow-up after a mean time of 6.7 ± 1.9 months were analysed. Clinical follow-up data of 151 of 183 patients (82.5%) were available. The study was approved by the local ethics committee (260/2015R). The decision for treatment by PMVR had been made by an interdisciplinary team of interventional cardiologists and cardiac surgeons based on either the EuroSCORE 6 or on the presence of specific surgical risk factors not covered in the EuroSCORE. Exclusion criteria for PMVR were as previously described. 7 Heart failure patients had to be on optimal medical treatment according to current guidelines for at least 3 months prior to PMVR treatment.
PMVR procedure
The procedure was carried out either in general anaesthesia or in deep sedation, generally as described before.
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Echocardiographic assessment
Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) measurements were obtained in the heart catheter laboratory after induction of general anaesthesia or deep sedation, respectively. Furthermore, TTE and TEE were evaluated again at follow-up (mean: 6.7 ± 1.9 months). For echocardiography, we used a Philips CX 50 or iE 33 machine (Philips HealthCare, Hamburg, Germany). All echocardiographic parameters were assessed at the beginning and at the end of the PMVR procedure and at follow-up. For the measurements pre PMVR, general anaesthesia or deep sedation were already in a steady state. Arterial blood pressure was kept within normal ranges in both the deep sedation and the general anaesthesia group using catecholamines and intravenous volume supplementation when necessary. The second measurements at the end of the procedure were carried out before general anaesthesia or deep sedation were ended. MR severity and the etiology of regurgitation were determined according to the current European Association of Echocardiography guidelines, MR pre-intervention, MR post-intervention and MR at follow-up was assessed using the technique described by Foster et al. and by TEE. 11, 12 3D TEE using the simultaneous biplane mode was applied to evaluate mitral valve geometry. The intercomissural medio-lateral (ml) view of the mitral valve was obtained in a mid-esophageal view at 50-70 with visualization of both papillary muscle heads. Then, using a simultaneous biplane mode a second plane was generated orthogonally to the first plane in the centre of the A2 segment allowing for evaluation of the maximum anterior-posterior diameter of the mitral valve. All echocardiographic loops were recorded. Mitral valve annulus diameter in medio-lateral and anterior-posterior (ap) dimension was measured in the respective views at end-systole ( Figure  1A) . 3 additional investigators blinded to the results repeated measurements using the Centricity Enterprise Web 3.0 software (GE medical systems, 540 West Northwest Highway, Barrington IL, USA). The mean of measurements was calculated and reported as final value. Coaptation length pre intervention was measured in the anterior-posterior view also used for clip positioning. Using simultaneous biplane mode, this view was generated in a plane exactly in the centre of the A2 segment of the intercomissural view. Post intervention, coaptation length was calculated using echo-loops of the grasping maneuver: The length of the visible part (outside the clip) of a leaflet was subtracted from the length of the respective leaflet before the grasping maneuver in a recorded loop. The mean of this difference for anterior mitral leaflet (AML) and posterior mitral leaflet (PML) is reported as the final value. When more than one clip was implanted, this procedure was performed for each single clip and the mean of the single measurements was calculated as final value. Moreover, mitral valve ellipticity was calculated, defined as mitral valve anterior-posterior diameter divided by the medio-lateral diameter. 13 Furthermore, we performed a parametric 3D quantification of the mitral valve annulus in a subset of 20 patients using the Philips Qlab 9.0 software (MVQ software) in zoomed 3D views of the mitral valve. Quantification was carried out in the end-systolic frame.
Statistical analysis
Statistical analysis was performed with SPSS (version 24, IBM Deutschland GmbH, Ehningen, Germany). Categorical variables are shown as absolute numbers or as percentage, continuous variables as means ± standard deviation (SD). Normal distribution of variables was tested using the ShapiroWilk test. For normally distributed data, paired t-Test was used to compare means. For not normally distributed data the Wilcoxon log rank test was used to compare means. The two-tailed P-values were calculated and a value of P < 0.05 was considered statistically significant. Echocardiographic views were assessed by four independent investigators, three of whom were blinded to the results. To evaluate reproducibility of echocardiographic measurements, the intra-class correlation coefficient for absolute agreement was used, with good agreement defined as > _0.80. For the assessment of intra-observer reliability, 20 randomly chosen patients were analysed by 1 investigator twice. Absolute agreement among the observations was calculated using intraclass correlation coefficient analysis. To compare agreement of 2D (simultaneous biplane mode) and 3D (parametric 3D quantification) measurements, Bland Altman analysis was used. 14 
Results
Baseline characteristics for all patients are depicted in Table 1 . Functional NYHA class III-IV was present in the majority of patients, and there was a high percentage of patients with severely reduced (<35% ejection fraction) LV-function. 57.9% of patients had functional MR (FMR) and 42.1% had degenerative MR (DMR). Coronary artery disease was previously diagnosed in 73.2% of the patients, was implanted in all 183 patients, all of whom had moderate to severe or severe (2þ to 4) MR at baseline. All patients had successful clip implantation. MR reduction of at least 2 grades was achieved in 180 of the patients (98.4%). There was no difference in the proportion of patients achieving MR severity < _2þ for patients with DMR or FMR.
PMVR using the MitraClip V R system causes changes in heart geometry associated with MR reduction. 15, 16 Figure 1A gives a schematic overview of the expected changes achieved by PMVR. By coaptation of the anterior and posterior leaflet of the mitral valve with increase in coaptation length, a reduction of mitral valve annulus size is accomplished and thereby MR is reduced. After clip implantation, we observed a significant increase in mitral valve coaptation length from 3.4 ± 1.0 to 8.4 ± 1.4 mm (P < 0.001, Figure 1B ). Echocardiographic measurements were checked for inter-and intra-observer reliability as described in the methods section ( Table 2) . PMVR procedures are increasingly carried out under conscious sedation. 17 Thus, clinical studies have to take any effects on haemodynamics into consideration. Here, we observed, however, no difference in haemodynamic parameters such as increase in cardiac output (CO) between patients treated in general anaesthesia (0.9 ± 1.4 L/min) vs. deep sedation (0.7 ± 1.2 L/min, P = 0.24, Figure 1C ). In line with our observation of increased leaflet coaptation after clip implantation, we measured a reduction of mitral valve annulus diameter in ap dimension (from 34.0 ± 4.3 to 31.3 ± 4.9, P < 0.001, Figure 2A ) and in ml dimension (from 33.2 ± 4.8 to 32.4 ± 4.9 mm, P < 0.001, Figure 2B ). Interestingly, mitral valve ellipticity (defined as mitral valve anterior-posterior diameter divided by the medio-lateral diameter) decreased significantly from 1.03 ± 0.16 to 0.98 ± 0.17 (P < _ 0.001, Figure 2C ). To evaluate the agreement of this biplane imaging method with volume 3D-imaging, we performed a parametric quantification of the mitral valve annulus in a subset of 20 patients. Zoomed 3D views of the mitral valve before and after the clip deployment were analysed in endsystole (see Supplementary data online, Figure S1A ). Bland Altman analysis showed good agreement of the two modes of analysis (mean difference 0.03 mm, 95% limits of agreement ± 7.1 mm, Supplementary data online, Figure S1B) . A significant reduction in mitral valve annulus ap diameter was observed in subgroups of functional MR (FMR, from 34.9 ± 3.9 to 32.1 ± 4.7 mm, P < 0.001, Figure  3A ) and degenerative MR (DMR, from 32. Mitral valve leaflet coaptation before and after PMVR was assessed. We observed a significant increase of MV coaptation length after PMVR (depicted is the median, the upper and the lower quartile, P < 0.001). (C) Haemodynamic parameters such as increase in cardiac output (CO) were comparable in patients undergoing deep sedation or general anaesthesia (depicted is the median, the upper and the lower quartile). n.s., no significant difference regarding change in CO after PMVR between the two groups. Figure 3C ). This reduction was more pronounced in FMR than in DMR. The reduction in ml diameter was significant in FMR (from 33.8 ± 4.3 to 32.8 ± 4.5, P = 0.001, Figure 3B ), however not in DMR (from 32.3± 5.4 to 31.8 ± 5.5, P = 0.16, Figure 3D ).
When we categorized our patient collective in two groups according to the number of implanted clips (1-2 clips vs. >2 clips), we found that patients requiring more than two clips were the ones with a larger left ventricular end-diastolic diameter (LVEDD) pre intervention (1-2 clips: 52.9 ± 9.8, more than two clips: 58.0 ± 9.0, P = 0.03, Figure 4A ). We also observed a significant correlation between the number of implanted clips and LVEDD pre PMVR (r = 0.19, P = 0.01, Figure 4B ) and the severity of MR at baseline (r = 0.21, P = 0.005, Figure 4C ).
We could demonstrate that the grade of residual MR shows a significant inverse correlation with the reduction in mitral valve annulus ap diameter (r = -0.15, P = 0.04, Figure 5A) . Analysis of the reduction in ml diameter showed no significant correlation with residual MR (r = -0.02, P = 0.75, Figure 5B) . Importantly, the reduction in MV annulus ap diameter was even more pronounced at follow-up after a mean time of 6.7 ± 1.9 months (31.3 ± 4.9 mm post PMVR, 28.4 ± 5.3 mm at follow-up, P < 0.001, Figure 5C ). The mean MR decreased from 3.6 ± 0.5 to 1.2 ± 0.6 and was 1.7 ± 0.5 at follow-up after 6.7 ± 1.9 months (P 0.001 compared to baseline, Figure 5D ). When dividing the study cohort into two groups according to the mitral valve annulus ap diameter post intervention, the group with an ap diameter smaller than 31.8 mm had a significantly smaller MR at follow-up than the group with a larger ap diameter (1.6 ± 0.5 vs. 1.8 ± 0.6, P = 0.01, Figure 5E ). Finally, we found a significant positive correlation between MR at follow-up and MV ap diameter at followup (r = 0.31, P = 0.005, Figure 5F ).
Discussion
The contribution of PMVR to mitral valve annular coaptation is not clear. Here, we describe for the first time in a larger patient collective that i) mitral annulus anterior posterior diameter is reduced and mitral valve coaptation length is enhanced after PMVR using the MitraClipV R system and ii) that residual MR significantly correlates with reduction in ap diameter in patients undergoing PMVR.
PMVR is a successful treatment option for patients with mitral regurgitation (MR) not eligible for conventional surgery. 18 Recently, 5 year data of the EVERST trial confirmed that PMVR more commonly required surgery for residual MR during the first year after treatment, but demonstrated comparably low rates of surgery for MV dysfunction with either percutaneous or surgical therapy after that period. 19 We and others were able to document positive changes in haemodynamics after PMVR with immediate increase of cardiac output. 9, 20, 21 Patients undergoing surgical mitral valve reconstruction are commonly treated with annuloplasty to achieve surgical PMVR using the MitraClip V R system is considered to reduce MR primarily by reducing mitral valve orifice area, while in-depth knowledge on whether this approach is associated with tightening of the mitral valve annulus is not available in larger patient collectives, so far. In general, the mitral ring is rather flexible and we could document a reduction in mitral annulus diameter in patients ventilated with elevated positive endexspiratory pressure (PEEP) in a preceding study. 7 Other previous reports using echocardiographic evaluation of PMVR suggested a reduction of mitral annulus diameter after edge-to-edge repair alone. 15, 16, 24 Our results in a larger cohort of patients undergoing PMVR are in line with these observations, as we observed a significant reduction of the mitral valve annular ap and ml diameter. Significant reductions in mitral valve annulus were measured in FMR and DMR. For DMR, the reduction reached statistical significance only for the ap diameter. Previous studies found a significant reduction in MV annulus diameter in FMR only. 15, 16, 24 The number of patients with DMR in these studies was 36, 15 14 16 and 24, 24 respectively. This might explain the failure to demonstrate significant annulus reduction in those smaller cohorts. In the present study, we were able to demonstrate reduction in mitral valve annulus diameters in a larger cohort of 77 patients with DMR. A possible explanation, why annulus diameter reduction is less in DMR might be that the mitral valve tissue is more rigid and less prone to changes in geometry.
Of the 183 patients included in the current study, 67 received 1 clip and 95 received two clips and 21 patients more than two clips.
Patients receiving more than 2 clips had a significantly larger LVEDD. There was a significant positive correlation between the number of implanted clips and the baseline LVEDD and with baseline MR. This indicates that patients receiving more clips had a more dilated left ventricle with altered mitral valve geometry resulting in increased severity of MR.
There are various approaches to achieve tightening of the mitral valve annulus by interventional techniques. Indirect annuloplasty using the Carrillon Mitral Contour V R System (Cardiac Dimensions, Inc., Kirkland, Washington) needs an internal jugular vein access to place a device for narrowing the annular circumference within the coronary sinus. 25 Furthermore, interventional devices such as the CardioBand V R System (Valtech Cardio, Or Yehuda, Israel) imitating the surgical approach are developed and have been applied in early phase clinical trials. 26 Currently, there is an ongoing and not conclusively resolved debate about the question, whether devices mediating tightening of the mitral valve annulus should be applied in addition or as pretreatment to PMVR using the MitraClip V R system. Our study adds further important aspects to this discussion, as a reduction of ap diameter, which embodies one central aspect modulating mitral annular architecture, could be achieved with the MitraClip V R system. Future prospective studies are needed to clarify the question of how many clips are needed for an optimal result and to define precise parameters when to choose to implant more than one clip.
Study limitations
This study has several limitations. One of the main limitations is the lack of a core laboratory for echocardiographic evaluation, although we calculated good inter-observer correlation. Furthermore, we cannot entirely rule out an influence of intraprocedural fluctuations of haemodynamics on mitral annular anatomy. We did not evaluate changes in mitral valve geometry over the complete heart cycle. All measurements of heart geometry were done at end-systole to obtain comparable results. We have to acknowledge the limited sample size, although this is-to our knowledge-the largest trial on mitral annular anatomy after PMVR, and given the complexity of the procedure, the patient number appeared reasonable to draw conclusions of potential clinical relevance. Nevertheless, while we demonstrate a reduction of mitral valve ap diameter associated with residual MR, future randomized studies will have to scrutinize the question, whether and in which chronology PMVR using the MitraClip V R system should be combined with further interventional approaches to improve leaflet coaptation at the mitral annulus level. Volume 3D-imaging may provide more accurate image plane selection for measurements and may allow more specific annulus measurements such as MV area or circumference.
Conclusions
Here, we assessed whether PMVR with the MitraClip V R system achieves tightening of the mitral valve annulus. We observed reduced mitral valve annulus diameter upon PMVR treatment associated with 
